AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 171 min read$PLXS

Kelsey Todd P. sold $364K of PLXS

Kelsey Todd P. (President & CEO) sold 1,500 shares of PLEXUS CORP (PLXS) at $242.41 ($0.36M total) on 2026-09-16 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Kelsey Todd P.
Published Sep 17, 2026, 9:12 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 9:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$PLXS
Neutral
medium confidence
Mentioned
$PLXS
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PLXSNeutralLow
01

Why it matters

The disclosed sale is modest and pre‑arranged, offering limited trading edge.

02

Market read

Provides a small‑scale insider sell signal for PLXS; unlikely to move the stock significantly.

03

What to watch

Potential upcoming product announcements or financing activities not disclosed.

Relevance 3/10Novelty 4/10Timing: post‑market 2026-09-16

Background

Form 4 filing discloses insider transactions required by SEC regulations.

Company-level read

Ticker impact

$PLXSNeutralMedium confidence
Context

CEO Kelsey Todd P. sold 1,500 shares for $363,615 via a 10b5-1 plan on 2026-09-16

Expected impact

Potential short‑term dip of 1‑2% if market reacts to the sale.

Evidence & confidence

The sale represents ~2.3% of the insider's post‑transaction holdings and is disclosed under a pre‑arranged plan, limiting informational value.

Market effects

Sector

Minimal impact on the broader medical‑device sector.

Regional

No significant regional effect.

Global

Limited to investors tracking Plexus Corp.

Counterpoint

What could challenge this read

The sale could be routine under the 10b5-1 plan and not reflect confidence.

Key entities

  • Company
    Plexus Corp

    Medical‑device manufacturer listed on NASDAQ under PLXS.

  • Individual
    Kelsey Todd P.

    President & CEO of Plexus Corp.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

PLXS insider trading history →

Related articles

JUL 29
$PLXSHigh

Plexus Announces Fiscal Third Quarter Financial Results

PLEXUS CORP (PLXS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Plexus Announces Fiscal Third Quarter Financial Results NEENAH, WI – July 29, 2026 - Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal third quarter ended July 4, 2026, and guidance for our fiscal fourth quarter ending October 3, 2026. • Reports record

SEC EDGAR 8-K6 min
OCT 7
$LWAYLow

Divisadero Street Capital Management, LP (Zolezzi William) purchased $2.2M of LWAY (indirect holdings)

Divisadero Street Capital Management, LP purchased 103,684 indirectly-held shares of Lifeway Foods, Inc. (LWAY) at an average of $20.92 ($20.80–$21.09, $2.17M total) across 3 trades over 2026-10-02 to 2026-10-06. Filed jointly with Divisadero Street Partners GP, LLC (10% owner), Zolezzi William (10% owner), Divisadero Street Partners, L.P. (10% owner) and Divisadero Street Capital, LLC (10% owner).

SEC EDGAR1 min